Market Indices
Latest News
 |
Citigroup analyst issues MARKET PERFORM recommendation for CHMI on August...
August 11, 2026 CHMI 16.01% |
| ||
| ||
| ||
|
Price Targets
from Stifel Nicolaus issued a price target of $3.00 for BAER on 2026-08-10 19:55:33.The adjusted price target was set to $3.00.At the time of the announcement, BAER...
August 10, 2026 BAER 8.73%
from Mizuho Securities issued a price target of $13.00 for VSTM on 2026-08-10 16:58:11.The adjusted price target was set to $13.00.At the time of the announcement, VSTM...
August 10, 2026 VSTM 0.74%
Swayampakula Ramakanth from H.C. Wainwright issued a price target of $7.00 for IPHA on 2026-08-10 16:27:19.The adjusted price target was set to $7.00.At the time of the announcement,
August 10, 2026 IPHA 28.32%
Matt Howlett from B.Riley Financial issued a price target of $3.10 for CHMI on 2026-08-10 13:25:00.The adjusted price target was set to $3.10.At the time of the announcement,
August 10, 2026 CHMI 16.01%
from D.A. Davidson issued a price target of $17.00 for LOCO on 2026-08-10 13:10:28.The adjusted price target was set to $17.00.At the time of the announcement, LOCO...
August 10, 2026 LOCO 0.26%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| EGRX Eagle Pharmaceuticals, In | 0.07
35.53% | ||||||||||||||||||
| IPHA Innate Pharma S.A. | 2.22
28.32% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 10.86
23.27% | ||||||||||||||||||
| NUTX Nutex Health, Inc. | 197.51
21.87% | ||||||||||||||||||
| VERU Veru Inc. | 2.77
18.88% | ||||||||||||||||||
| CBAT CBAK Energy Technology, I | 0.77
18.47% | ||||||||||||||||||
| UEIC Universal Electronics Inc | 5.56
16.81% | ||||||||||||||||||
| CHMI Cherry Hill Mortgage Inve | 2.79
16.01% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -8.90%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -11.85%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.41%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.47%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.06%